The splice variants of vascular endothelial growth factor (VEGF) and their receptors

Journal of Cell Science

Volumn 114, Issue 5, 2001, Pages 853-865

  Robinson, Christopher J ^b   Stringer, Sally E ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NONE

Author keywords

Angiogenesis; Heparan sulphate proteoglycan; Hypoxia; Neuropilin; VEGF; VEGFR

Indexed keywords

ISOPROTEIN; MESSENGER RNA; MITOGENIC AGENT; PROTEIN TYROSINE KINASE; PROTEOHEPARAN SULFATE; TYROSINE KINASE RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BIOCHEMISTRY; BLOOD VESSEL PERMEABILITY; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VIVO STUDY; LIGAND BINDING; MICROVASCULARIZATION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; SPLICEOSOME; TREATMENT PLANNING; TUMOR VASCULARIZATION;

ALTERNATIVE SPLICING; ANIMALS; ENDOTHELIAL GROWTH FACTORS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; LYMPHOKINES; NERVE TISSUE PROTEINS; NEUROPILIN-1; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0035062394     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (16)

1. Abe, K., Shoji, M., Chen, J., Bierhaus, A., Danave, I., Micko, C., Casper, K., Dillehay, L., Nawroth, P. P. and Rickles, F. R. (1999). Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc. Nat. Acad. Sci. USA 96, 8663-8668.
2. Achen, M. G., Jeltsch, M., Kukk, E., Makinen, T., Vitali, A., Wilks, A. F., Alitalo, K. and Stacker, S. A. (1998). Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk-1) and VEGF receptor 3 (Flt-4). Proc. Nat. Acad. Sci. USA 95, 548-553.
3. Akiri, G., Nahari, D., Finkelstein, Y., Le, S. Y., Elroy-Stein, O. and Levi, B. Z. (1998). Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription. Oncogene 17, 227-236.
4. Alon, T., Hemo, I., Itin. A., Pe'er. J., Stone, J. and Keshet, E. (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 10, 1024-1028.
5. Anthony, F. W., Wheeler, T., Elcock, C. L., Pickett, M. and Thomas, E. J. (1994). Short report: identification of a specific pattern of vascular endothelial growth factor mRNA expression in human placenta and cultured placental fibroblasts. Placenta 15, 557-561.
6. Asahara, T., Bauters, C., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J. F. and Isner, J. M. (1995). Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92, 365-371
7. Bacic, M., Edwards, N. A. and Merrill, M. J. (1995). Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues. Growth Factors 12, 11-15.
8. Barleon, B., Sozzani, S., Zhou, D., Weich, H. A., Mantovani, A. and Marme, D. (1996). Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor Flt-1. Blood 87, 3336-3343.
9. Barleon, B., Totzke, F., Herzog, C., Blanke, S., Kremmer, E., Siemeister, G., Marme, D. and Martiny-Baron, G. (1997a). Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J. Biol. Chem. 272, 10382-10388.
10. Barleon, B., Siemeister, G., Martiny-Baron, G., Weindel, K., Herzog, C. and Marme, D. (1997b). Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res. 57, 5421-5425.
11. Benjamin, L. E. and Keshet, E. (1997). Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Nat. Acad. Sci. USA 94, 8761-8766.
12. Boensch, C., Kuo, M. D., Connolly, D. T., Huang, S. S. and Huang, J. S. (1995). Identification, purification, and characterization of cell-surface retention sequence-binding proteins from human SK-Hep cells and bovine liver plasma membranes. J. Biol. Chem. 270, 1807-1816.
13. Brogi, E., Wu, T., Namiki, A. and Isner, J. M. (1994). Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 2, 649-652.
14. Brogi, E., Schatteman, G., Wu, T., Kim, E. A., Varticovski, L., Keyt, B. and Isner, J. M. (1996). Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Invest. 97, 469-476.
15. Cai, H. and Reed, R. R. (1999). Cloning and characterization of neuropilin-1-interacting protein: a PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1. J. Neurosci. 19, 6519-6527.
16. Cao, Y., Chen, H., Zhou, L., Chiang, M. K., Anand-Apte, B., Weatherbee, J. A., Wang, Y., Fang, F., Flanagan, J. G. and Tsang, M. L. (1996). Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR J. Biol. Chem. 271, 3154-3162.